Dr. Reddy's names Milan Kalawadia CEO North America
Dr. Reddy's has appointed Milan Kalawadia as CEO, North America, and member of the management council. As part of the Dr. Reddy’s senior leadership team, he will be responsible for the company’s North America business and will be based out of the Princeton, N.J. office.
“I am excited to start this next chapter in my journey at Dr. Reddy’s,” said Kalawadia. “I have been fortunate to be a part of a remarkable team that has achieved significant milestones over that last 18 years. I now look forward to leveraging the relationships I have built over my years within the organization, as well as the industry connections I have made to continue to lead the North America division to new heights.”
During his 18-year tenure at Dr. Reddy’s, Kalawadia has held various positions of increasing responsibility beginning in 2006 with roles in finance, investor relations, corporate/business development, marketing and head of NAG OTC and SRx divisions. Most recently, he served as chief commercial officer, responsible for the customer-facing and commercialization operations for the three main verticals of the core NA business: retail Rx, hospital/institutional injectable and private label OTC.
[Read more: Dr. Reddy's acquires MenoLabs from Amyris]
Kalawadia led the early efforts to develop strategies for the biosimilars and the self-care and wellness business units in the U.S. He played a critical role in driving various new growth initiatives including the acquisition of OTC brands; the development of an e-commerce presence on Amazon; and engaging with alternate channel partners.
“During the last three years, Milan’s efforts as chief commercial officer were instrumental in driving North America to three consecutive years of growth over the $1 billion revenue threshold and achieving record sales in FY24,” said Erez Israeli, CEO of Dr. Reddy’s. “His track record and deep understanding of the industry, coupled with his passion for innovation and customer-centric approach, make him the ideal candidate to lead the North America business unit into its next chapter of success.”
Kalawadia holds a Bachelor of Science degree in Management Science and Information Systems from Rutgers University, School of Business; and a Master of Business Administration degree from Carnegie Mellon University, Tepper School of Business.
[Read more: Alvotech, Dr. Reddy’s collaborate for biosimilar candidate to Prolia, Xgeva]